Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group.
Fountzilas E, Lampaki S, Koliou GA, Koumarianou A, Levva S, Vagionas A, Christopoulou A, Laloysis A, Psyrri A, Binas I, Mountzios G, Kentepozidis N, Kotsakis A, Saloustros E, Boutis A, Nikolaidi A, Fountzilas G, Georgoulias V, Chrysanthidis M, Kotteas E, Vo H, Tsiatas M, Res E, Linardou H, Daoussis D, Bompolaki I, Andreadou A, Papaxoinis G, Spyratos D, Gogas H, Syrigos KN, Bafaloukos D. Fountzilas E, et al. Among authors: daoussis d. Cancer Immunol Immunother. 2022 Feb;71(2):327-337. doi: 10.1007/s00262-021-02985-6. Epub 2021 Jun 23. Cancer Immunol Immunother. 2022. PMID: 34164709 Free PMC article.
Primary Sjögren's Syndrome and Cardiovascular Disease.
Melissaropoulos K, Bogdanos D, Dimitroulas T, Sakkas LI, Kitas GD, Daoussis D. Melissaropoulos K, et al. Among authors: daoussis d. Curr Vasc Pharmacol. 2020;18(5):447-454. doi: 10.2174/1570161118666200129125320. Curr Vasc Pharmacol. 2020. PMID: 31995009 Review.
Immune checkpoint inhibitor-induced musculoskeletal manifestations.
Angelopoulou F, Bogdanos D, Dimitroulas T, Sakkas L, Daoussis D. Angelopoulou F, et al. Among authors: daoussis d. Rheumatol Int. 2021 Jan;41(1):33-42. doi: 10.1007/s00296-020-04665-7. Epub 2020 Aug 2. Rheumatol Int. 2021. PMID: 32743706 Review.
A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease.
Daoussis D, Melissaropoulos K, Sakellaropoulos G, Antonopoulos I, Markatseli TE, Simopoulou T, Georgiou P, Andonopoulos AP, Drosos AA, Sakkas L, Liossis SN. Daoussis D, et al. Semin Arthritis Rheum. 2017 Apr;46(5):625-631. doi: 10.1016/j.semarthrit.2016.10.003. Epub 2016 Oct 13. Semin Arthritis Rheum. 2017. PMID: 27839742
109 results